These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 21969559)

  • 1. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
    Meyer C; Sevko A; Ramacher M; Bazhin AV; Falk CS; Osen W; Borrello I; Kato M; Schadendorf D; Baniyash M; Umansky V
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17111-6. PubMed ID: 21969559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation.
    Umansky V; Sevko A
    Cancer Immunol Immunother; 2012 Feb; 61(2):275-282. PubMed ID: 22120757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
    Sevko A; Sade-Feldman M; Kanterman J; Michels T; Falk CS; Umansky L; Ramacher M; Kato M; Schadendorf D; Baniyash M; Umansky V
    J Invest Dermatol; 2013 Jun; 133(6):1610-9. PubMed ID: 23223128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
    Sevko A; Michels T; Vrohlings M; Umansky L; Beckhove P; Kato M; Shurin GV; Shurin MR; Umansky V
    J Immunol; 2013 Mar; 190(5):2464-71. PubMed ID: 23359505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.
    Umansky V; Blattner C; Gebhardt C; Utikal J
    Cancer Immunol Immunother; 2017 Aug; 66(8):1015-1023. PubMed ID: 28382399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
    Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
    Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.
    Iannone R; Miele L; Maiolino P; Pinto A; Morello S
    Neoplasia; 2013 Dec; 15(12):1400-9. PubMed ID: 24403862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.
    Weber R; Riester Z; Hüser L; Sticht C; Siebenmorgen A; Groth C; Hu X; Altevogt P; Utikal JS; Umansky V
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5
    Blattner C; Fleming V; Weber R; Himmelhan B; Altevogt P; Gebhardt C; Schulze TJ; Razon H; Hawila E; Wildbaum G; Utikal J; Karin N; Umansky V
    Cancer Res; 2018 Jan; 78(1):157-167. PubMed ID: 29089297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment.
    Lesokhin AM; Hohl TM; Kitano S; Cortez C; Hirschhorn-Cymerman D; Avogadri F; Rizzuto GA; Lazarus JJ; Pamer EG; Houghton AN; Merghoub T; Wolchok JD
    Cancer Res; 2012 Feb; 72(4):876-86. PubMed ID: 22174368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma.
    Tähtinen S; Blattner C; Vähä-Koskela M; Saha D; Siurala M; Parviainen S; Utikal J; Kanerva A; Umansky V; Hemminki A
    J Immunother; 2016; 39(9):343-354. PubMed ID: 27741089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma.
    Lengagne R; Pommier A; Caron J; Douguet L; Garcette M; Kato M; Avril MF; Abastado JP; Bercovici N; Lucas B; Prévost-Blondel A
    PLoS One; 2011; 6(5):e20235. PubMed ID: 21633700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.
    Serafini P; Mgebroff S; Noonan K; Borrello I
    Cancer Res; 2008 Jul; 68(13):5439-49. PubMed ID: 18593947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8
    Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF inhibition alleviates immune suppression in murine autochthonous melanoma.
    Steinberg SM; Zhang P; Malik BT; Boni A; Shabaneh TB; Byrne KT; Mullins DW; Brinckerhoff CE; Ernstoff MS; Bosenberg MW; Turk MJ
    Cancer Immunol Res; 2014 Nov; 2(11):1044-50. PubMed ID: 25183499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.